Patten Group’s Novo Nordisk NVO Stock Holding History

Patten Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-150	Closed	-$4K	–	673
2018 Q1	$4K	Hold	150	–	–	﹤0.01%	525
2017 Q4	$4K	Hold	150	–	–	﹤0.01%	554
2017 Q3	$4K	Hold	150	–	–	﹤0.01%	546
2017 Q2	$3K	Hold	150	–	–	﹤0.01%	578
2017 Q1	$3K	Hold	150	–	–	﹤0.01%	566
2016 Q4	$3K	Hold	150	–	–	﹤0.01%	543
2016 Q3	$2.97K	Hold	150	–	–	﹤0.01%	557
2016 Q2	$4.03K	Hold	150	–	–	﹤0.01%	532
2016 Q1	$4.06K	Hold	150	–	–	﹤0.01%	554
2015 Q4	$4.36K	Hold	150	–	–	﹤0.01%	577
2015 Q3	$4.07K	Hold	150	–	–	﹤0.01%	512
2015 Q2	$4.11K	Buy	+150	New	+$4.22K	﹤0.01%	522

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Patten Group's NVO Position: Q2 2018 in Review

Patten Group sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 150 shares — an estimated $4K sold.

Patten Group first reported a position in NVO in Q2 2015 and held it in 12 quarters. The position peaked at $4.36K in Q4 2015. 536 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

Patten Group reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
Patten Group sold 150 Novo Nordisk shares in Q2 2018, an estimated $4K.
Patten Group first reported a position in Novo Nordisk in Q2 2015 and held it in 12 quarters.
Patten Group's Novo Nordisk position peaked at $4.36K in Q4 2015.
536 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on Patten Group's 13F filing for Q2 2018, filed 14 Aug 2018.